BridgeBio Pharma, Inc 10-Q for FY2021 Q2
BridgeBio Pharma, Inc. (BBIO)
10-Q
2021-08-05
For: 2021-06-30
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on August 5, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).
Headline figures
Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $54.02M
- Net loss
- $102.07M
- compared with a net loss of $136.21M a year earlier